Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Springer Seminars in Immunopathology
|
January 1, 1996
Genetically engineered superantigens in experimental tumor therapy
P Antonsson, J Hansson, T Kalland, et al.
British Journal of Cancer
|
July 5, 2001
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
G Forsberg, L Ohlsson, T Brodin, et al.
Molecular and Cellular Probes
|
October 21, 2000
Rapid and specific detection of PCR products using light-up probes
J Isacsson, H Cao, L Ohlsson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 1997
Genetically engineered superantigens as tolerable antitumor agents
J Hansson, L Ohlsson, R Persson, et al.
BMC Medical Imaging
|
December 17, 2008
Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defect
Lene Rosendahl, Peter Blomstrand, Jan L Ohlsson, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
September 1, 1996
Antibody-targeted superantigens in cancer immunotherapy
M Søgaard, J Hansson, M J Litton, et al.
Scandinavian Journal of Gastroenterology
|
August 10, 1999
Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study
V Meineche-Schmidt, N J Talley, A Pap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis
T C Sarich, J I Osende, U G Eriksson, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Springer Seminars in Immunopathology
|
January 1, 1996
Genetically engineered superantigens in experimental tumor therapy
P Antonsson, J Hansson, T Kalland, et al.
British Journal of Cancer
|
July 5, 2001
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
G Forsberg, L Ohlsson, T Brodin, et al.
Molecular and Cellular Probes
|
October 21, 2000
Rapid and specific detection of PCR products using light-up probes
J Isacsson, H Cao, L Ohlsson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 1997
Genetically engineered superantigens as tolerable antitumor agents
J Hansson, L Ohlsson, R Persson, et al.
BMC Medical Imaging
|
December 17, 2008
Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defect
Lene Rosendahl, Peter Blomstrand, Jan L Ohlsson, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
September 1, 1996
Antibody-targeted superantigens in cancer immunotherapy
M Søgaard, J Hansson, M J Litton, et al.
Scandinavian Journal of Gastroenterology
|
August 10, 1999
Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study
V Meineche-Schmidt, N J Talley, A Pap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis
T C Sarich, J I Osende, U G Eriksson, et al.
Page
of 6